Human Rnase P Equipment Supplied In USA

COVID-19 caused by the SARS-COV-2 virus, and influenza by influenza viruses are respiratory tract infections that display overlapping symptoms. Moreover, novel strains of influenza A and B viruses are unpredictable and may cause pandemics like 1918, 1957, 1968, 1977, 2009 by an H1N1, H2N2, H3N2, H1N1, and H1N1/09 subtypes, respectively. In the event of coinfections of these viruses, especially ...

The AccuPlex SARS-CoV-2 Reference Material Kit contains positive reference material directed against the published CDC and WHO consensus sequences. Also included are negative controls targeting the human RNAse P gene. In cases where true patient samples are difficult to source or too risky to directly handle, AccuPlex technology provides the ...

OPTI Medical Systems has obtained CE marking for its OPTI SARS-CoV-2/Influenza A/B RT-PCR Test for identification and differentiation of SARS-CoV-2, influenza A, and influenza B RNA. The test is available in countries accepting the CE mark. This respiratory panel distinguishes between SARS-CoV-2 and influenza A and B extracted from nasopharyngeal swabs. Use of this test is ideal for identifying ...

The Mplex Monkeypox, Orthopox is a research use only (RUO) Real-time PCR assay designed for the simultaneous qualitative detection of the monkeypox virus and its differentiation from other orthopox viruses. Sample material should be DNA extracted from human upper respiratory specimen types, whole blood, serum or pustule specimen types. ...

EZ™-SARS-CoV-2 Real-Time RT-PCR is a real-time RT-PCR test intended for the qualitative detection of RNA from the SARS-CoV-2 in human nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high ...